iwCLL Capacity Development Project

Deadline: Friday 27 March 2026 at 17:00 CET

The purpose of this funding opportunity is to foster the development of CLL related diagnostics, inform treatment decisions and clinical management from real-world evidence studies in collaboration with ERIC, build capacity in translational research, foster patient advocacy in an LMIC (ODA) country according to the ODA list with the ultimate aim to better understand CLL globally and improve patient outcomes. It offers a funding structure for innovative projects in any of the above aspects.

Level of funding

The maximum grant awarded will be $100,000. The award amount is determined by the cost of the project based on the region in which it is conducted and the duration of the project.

Duration of funding 

1-3 years

Scope of the grant

iwCLL is looking to support the early-stage development of interventions that seek to address either regional or global CLL related challenges. The project could be focused on capacity building in translational research, laboratory or clinical management, however, emphasis should be on early stage interventions that are ideally linked to a longer-term sustainability plan.

Examples of supported projects include, but are not limited to:

  • Translational, clinical or outcomes-based research projects
  • Projects advancing CLL specific diagnostic and prognostic capabilities of laboratories
  • Collecting real-world evidence on CLL patients as part of ERIC’s federated database initiative
  • Establishment of a comprehensive CLL clinic
  • Setting up of a CLL clinical trial unit
  • Patient advocacy-based themes to improve the quality of care delivered to CLL patients and access to treatment.

Eligibility and suitability

You need to be an exceptional individual with a higher degree in haematology or a PhD in a haematology-based project with the ability to strengthen capacity of CLL clinical services and research capacity.  You should be based in an LMIC country and the proposed project should be based in that country or region. 

You need to be able to demonstrate:

  • an employment contract for at least three years
  • a specific interest and ideally a track record focused on CLL at the time of application
  • strong and sustained support by your home institution that allows to leverage the award by multiplying its impact on the outcome of CLL patients in the region

How to apply

Please apply through our on-line application form

Capacity Development Project form

What your application should include:

  • Project title
  • Brief description of the project and predicted impact
  • Key project goals and objectives
  • Evidence gap and how the proposed intervention would fill that gap 
  • Full description of the project;
  • background
  • scientific rationale (where applicable)
  • methods
  • utility
  • applicability
  • affordability and feasibility
  • Proposed impact of the project on:
  • patients with CLL and their families
  • the local healthcare facility and research organisation
  • the healthcare system
  • the wider clinical and research community of CLL and beyond
  • Criteria for its evaluation that will define progression to the next stage of development
  • Project timeline including measurable milestones and outputs
  • Demonstration of a pathway to further develop the intervention and longer-term sustainability plan
  • Opportunities for Patient and Public Involvement
  • Costs 
  • Proposed cost breakdown of the project
  • Justification of costs
  • About you
    • Your CV
    • Brief description of your career level and aspirations 
    • Brief description of the home institution supporting you as the applicant and of the nature of support provided to aid you to become an opinion leader in the field of CLL
    • Evidence of strong mentorship by a senior clinician or scientist from a centre of excellence

For visiting training fellowships only:

  • Justification for choosing this specific centre of excellence

For research projects and registries only:

  • Approach to data sharing and confidentiality
  • Ethical implications 

Evaluation and selection process

All applications will be reviewed by the iwCLL Global Partnerships Subcommittee and the iwCLL Grant Review Subcommittee.  The scoring template used to review the applications will be as follows:

All applications will be reviewed by the iwCLL Global Partnerships Subcommittee and ratified by the iwCLL Executive Board. The scoring template used to review the applications will be as follows:

RELEVANCE – The extent to which the intervention objectives and design respond to the need of beneficiaries both regionally and globally and the alignment with iwCLL objectives.

FEASIBILITY – Practical feasibility of the intervention proposed with the available grant and the value for money of the proposed project. This also includes the capabilities and sustainability of your assembled team to deliver the proposed project and feasibility of delivering the proposed programme of work within the time frame of the available grant

COHERENCE – The compatibility of the intervention with existing facilities/interventions in the region

EXCELLENCE – whether specific objectives of the project demonstrate excellence and originality, with a clear and well-developed rationale for engaging partners with appropriate skills from relevant disciplines and make a significant contribution to the advancement of the area

EFFECTIVENESS – The extent to which the intervention is expected to achieve the objective, taking into account the relative importance of the objectives or results

EFFICIENCY – The extent to which the intervention delivers, or is likely to deliver, results in an economical and timely way- Is the proposed intervention the most cost-effective way of delivering the objective/results.

IMPACT – The extent to which the intervention will make intended and unintended effects on the population it affects. 

SUSTAINABILITY – The extent to which the net benefits of the intervention continue, or are likely to continue. 

The applications will be reviewed by members of the iwCLL Global Partnerships Subcommittee especially by regional representatives of the subcommittee to assess the relevance of the project in the corresponding region, their decision will be ratified by the iwCLL Executive Board.

We will assess your proposal on various aspects including evaluation criteria of the project as outlined above, the track record of the main proposer, how well the project aligns with the capabilities of the team doing the project and the strength of the institution providing support for the project. 

A decision will be made in approximately eight weeks after the closing date and feedback will be provided to applicants in the next four weeks.

Applications which are outside the scope of the opportunity will not be assessed.

Key Dates 

Application deadline: Friday 27 March 2026

Application review: April – May 2026

Decision: by Friday 29 May 2026

Requirements for the successful applicant

The successful applicant will be asked to enter into a Funding Agreement with iwCLL

iwCLL-Capacity-Development-Project-Draft-Funding-Agreement- (152kB pdf)

Contact Us 

If you have questions relating to your application please contact the iwCLL Executive Office.